Old National Bancorp Aerie Pharmaceuticals Inc Transaction History

Old National Bancorp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$4.95 - $9.16 $15,929 - $29,476	-3,218 Reduced 15.84%	17,092 $128,000
Q1 2022 May 09, 2022	BUY	$5.64 - $9.8 $21,821 - $37,916	3,869 Added 23.53%	20,310 $185,000
Q4 2021 Jan 25, 2022	SELL	$7.02 - $13.33 $3,531 - $6,704	-503 Reduced 2.97%	16,441 $115,000
Q3 2021 Oct 25, 2021	BUY	$11.32 - $16.63 $191,806 - $281,778	16,944 New	16,944 $193,000
Q2 2021 Jul 26, 2021	SELL	$15.16 - $18.97 $263,556 - $329,793	-17,385 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$13.12 - $20.9 $155,537 - $247,769	-11,855 Reduced 40.54%	17,385 $311,000
Q4 2020 Jan 19, 2021	BUY	$9.12 - $14.49 $12,147 - $19,300	1,332 Added 4.77%	29,240 $395,000
Q3 2020 Oct 29, 2020	BUY	$10.46 - $14.46 $170,874 - $236,218	16,336 Added 141.17%	27,908 $328,000
Q2 2020 Jul 27, 2020	BUY	$12.0 - $16.13 $138,864 - $186,656	11,572 New	11,572 $171,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.